We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Extra Virgin Avocado Oil for those that live busy lifestyles but enjoy healthy snacking. South Press Co's avocado oil is cold-pressed and derived from the high-grade African avocados. Their oil is available in more than 500 Tesco stores and is sold on Amazon. Since launching in 2016, more than 375,000 bottles have been sold to date. The company is now expanding their business and using their oil in crisps products, dubbed LENTILPOPS®, the first crisps brand in the UK to be made using avocado oil. This new range will contain 60% less fat compared with competing products and will be vegan and gluten, soy and lactose-free. South Press Co will also be launching their brand in the US via an e-commerce platform in January 2019, with distribution to physical retailers by the summer.
days to go: Expired investment: £158,530
Race Space have created an endurance event directory for the 21st century that is designed to uncomplicate the online experience of finding and entering events.  
days to go: Expired investment: £111,583
Plant-based diets, health and fitness programmes for those interested in veganism to improve their health and wellbeing. Skinny Bitch's book has sold more than 1.1m copies and is available in 6 languages. Readers of the book include celebrities such as Eva Longoria and Jessica Alba. Ellen DeGeneres has stated that the Skinny Bitch book is the reason she became vegan. The company is now expanding their brand further by offering their content through online guides and blogs. Skinny Bitch is also intending to generate revenue via vegan supplements produced in the US to be sold through their website and third party e-commerce channels.
days to go: Expired investment: £75,810
Drop Drinks creates vintage beverages with a distinctive taste. Theses beverages are inspired by traditional British sweets like Pear Drop and Cherry Drop. The company has sold more than 10,000 units since its launch in 2018. With more than 9,000 followers on social platforms such as Facebook and Instagram, Drop Drinks aims at increasing its product range to become a popular and leading drink brand domestically and grow globally. The company is now raising funds to increase production, execute an extensive go-to-market strategy, and hire key staff.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £127,690
Her.9 is a Direct-To-Consumer (DTC) female technology brand that caters to the needs of women during pregnancy. It cites research arguing that up to 40% of women taking prenatal vitamins may not be able to absorb the folic acid within the UK’s leading pregnancy brand. Her.9 aims to resolve this by employing DUOCAP technology. The company asserts that DUOCAP is a capsule-in-capsule delivery system which contains solubilised prebiotics in the outer capsule and probiotics in the inner capsule. The prebiotic releases immediately and the probiotic releases later allowing for targeted supplement delivery in the body. The prenatal supplements market is set to be worth $56 billion globally by 2024. Her.9 aims to be a notable contender in this segment. The company is raising investment to build its already established partnerships and execute its marketing strategy effectively.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £215,946
Drop Bear Beer Co. aims in disrupting and exciting the alcohol-free beer market. It is the only female-run alcohol-free craft beer company. Drop Bear Beer Co.'s May 2019 launch was a success as it experienced sales of 3000 units in one month. The company is a winner of the Wales Start-Up of the Year Awards 2019. With the proceeds, Drop Bear Beer Co. will finalise core range within 12 months, scale-up production, make range available in cans, and arrange a large brand-building campaign.
days to go: Expired investment: £172,570
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph